002727 Stock Overview Together with its subsidiary, operates a chain of drugstores in China. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Add noteYixintang Pharmaceutical Group Co., Ltd. Competitors Price History & Performance
Summary of share price highs, lows and changes for Yixintang Pharmaceutical Group Historical stock prices Current Share Price CN¥13.95 52 Week High CN¥24.57 52 Week Low CN¥10.84 Beta 0.40 1 Month Change 2.72% 3 Month Change 23.12% 1 Year Change -37.33% 3 Year Change -60.84% 5 Year Change -38.82% Change since IPO -35.27%
Recent News & Updates
Third quarter 2024 earnings released: EPS: CN¥0.018 (vs CN¥0.30 in 3Q 2023) Oct 31
Yixintang Pharmaceutical Group Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024 Sep 30
Investor sentiment improves as stock rises 18% Sep 27
Second quarter 2024 earnings released: EPS: CN¥0.067 (vs CN¥0.45 in 2Q 2023) Aug 31
Yixintang Pharmaceutical Group Co., Ltd. (SZSE:002727) commences an Equity Buyback Plan for CNY 150 million worth of its shares, under the authorization approved on July 2, 2024. Jul 26 Yixintang Pharmaceutical Group Co., Ltd. (SZSE:002727) commences an Equity Buyback Plan for CNY 150 million worth of its shares, under the authorization approved on July 2, 2024. Jul 25
See more updates
Third quarter 2024 earnings released: EPS: CN¥0.018 (vs CN¥0.30 in 3Q 2023) Oct 31
Yixintang Pharmaceutical Group Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024 Sep 30
Investor sentiment improves as stock rises 18% Sep 27
Second quarter 2024 earnings released: EPS: CN¥0.067 (vs CN¥0.45 in 2Q 2023) Aug 31
Yixintang Pharmaceutical Group Co., Ltd. (SZSE:002727) commences an Equity Buyback Plan for CNY 150 million worth of its shares, under the authorization approved on July 2, 2024. Jul 26 Yixintang Pharmaceutical Group Co., Ltd. (SZSE:002727) commences an Equity Buyback Plan for CNY 150 million worth of its shares, under the authorization approved on July 2, 2024. Jul 25
Now 20% overvalued Jul 05
Yixintang Pharmaceutical Group Co., Ltd. to Report First Half, 2024 Results on Aug 31, 2024 Jun 29
Dividend of CN¥0.40 announced May 26
Yixintang Pharmaceutical Group Co., Ltd. Announces Dividend Implementation for 2023, Payable on 30 May 2024 May 25
Yixintang Pharmaceutical Group Co., Ltd., Annual General Meeting, May 21, 2024 Apr 29
Yixintang Pharmaceutical Group Co., Ltd., Annual General Meeting, May 21, 2024 Apr 28
First quarter 2024 earnings released: EPS: CN¥0.41 (vs CN¥0.40 in 1Q 2023) Apr 27
Yixintang Pharmaceutical Group Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024 Mar 30
Full year 2023 earnings released: EPS: CN¥0.92 (vs CN¥1.70 in FY 2022) Mar 19
New minor risk - Profit margin trend Mar 19
Now 21% undervalued after recent price drop Jan 30
Yixintang Pharmaceutical Group Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024 Dec 30
Third quarter 2023 earnings released: EPS: CN¥0.30 (vs CN¥0.44 in 3Q 2022) Nov 01
Second quarter 2023 earnings released: EPS: CN¥0.45 (vs CN¥0.40 in 2Q 2022) Aug 22
Yixintang Pharmaceutical Group Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 26 May 2023 May 20
Yixintang Pharmaceutical Group Co., Ltd. Approves Cash Dividend for the Year 2022 May 18
Full year 2022 earnings released: EPS: CN¥1.70 (vs CN¥1.56 in FY 2021) Mar 18
Investor sentiment improved over the past week Dec 04
Investor sentiment improved over the past week Nov 18
Insufficient new directors Nov 16
Third quarter 2022 earnings released: EPS: CN¥0.44 (vs CN¥0.41 in 3Q 2021) Oct 28
Second quarter 2022 earnings released: EPS: CN¥0.40 (vs CN¥0.45 in 2Q 2021) Aug 19
Investor sentiment improved over the past week Jul 21
First quarter 2022 earnings released: EPS: CN¥0.30 (vs CN¥0.44 in 1Q 2021) May 02
High number of new directors Apr 27
Yixintang Pharmaceutical Group Co., Ltd. Proposes Cash Dividend on A Shares for the Year 2021, Payable on April 29, 2022 Apr 23
Yixintang Pharmaceutical Group Co., Ltd. Approves Profit Distribution Apr 22
Yixintang Pharmaceutical Group Co., Ltd., Annual General Meeting, Apr 20, 2022 Apr 02
Yixintang Pharmaceutical Group Co., Ltd. Proposes Final Cash Dividend for the Year 2021 Mar 31
Full year 2021 earnings: EPS in line with expectations, revenues disappoint Mar 16
Now 22% undervalued after recent price drop Feb 23
Investor sentiment improved over the past week Dec 10
Third quarter 2021 earnings released: EPS CN¥0.41 (vs CN¥0.33 in 3Q 2020) Oct 31
Second quarter 2021 earnings released: EPS CN¥0.45 (vs CN¥0.37 in 2Q 2020) Jul 25
First quarter 2021 earnings released: EPS CN¥0.44 (vs CN¥0.36 in 1Q 2020) Apr 30
Investor sentiment improved over the past week Mar 22
Yixintang Pharmaceutical Group Co., Ltd. Proposes Final Cash Dividend for the Year 2020 Mar 17
Full year 2020 earnings released: EPS CN¥1.38 (vs CN¥1.06 in FY 2019) Mar 16
Full year 2020 earnings released: EPS CN¥1.38 (vs CN¥1.06 in FY 2019) Feb 09
New 90-day high: CN¥46.68 Feb 09
Revenue beats expectations Feb 09
Yixintang Pharmaceutical Group Co., Ltd. to Report Fiscal Year 2020 Results on Mar 16, 2021 Jan 22
Investor sentiment improved over the past week Jan 13
New 90-day low: CN¥32.38 Jan 07
New 90-day low: CN¥34.00 Dec 23
Investor sentiment deteriorated over the past week Dec 23
New 90-day high: CN¥42.23 Dec 04
Laobaixing Reportedly in Merger Talks with Yixintang Nov 05
Third quarter earnings released Oct 29
New 90-day high - CN¥38.50 Aug 25
First half earnings released Aug 19
Yixintang Pharmaceutical Group Co., Ltd. to Report First Half, 2020 Results on Aug 19, 2020 Jul 24 Shareholder Returns 002727 CN Consumer Retailing CN Market 7D -4.9% -6.3% -1.2% 1Y -37.3% 5.8% 11.8%
See full shareholder returns
Return vs Market: 002727 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility Is 002727's price volatile compared to industry and market? 002727 volatility 002727 Average Weekly Movement 6.7% Consumer Retailing Industry Average Movement 8.6% Market Average Movement 8.7% 10% most volatile stocks in CN Market 12.8% 10% least volatile stocks in CN Market 5.7%
Stable Share Price: 002727 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002727's weekly volatility (7%) has been stable over the past year.
About the Company Yixintang Pharmaceutical Group Co., Ltd., together with its subsidiary, operates a chain of drugstores in China. It also produces and sells medicinal materials, Chinese herbal medicines, and food and health products, as well as engages in the drug distribution activities. It operates stores in Yunnan, Guizhou, Guangxi, Sichuan, Shanxi, Chongqing, Tianjin, Shanghai, Qiong, and other provinces and municipalities.
Show more Yixintang Pharmaceutical Group Co., Ltd. Fundamentals Summary How do Yixintang Pharmaceutical Group's earnings and revenue compare to its market cap? 002727 fundamental statistics Market cap CN¥8.19b Earnings (TTM ) CN¥156.02m Revenue (TTM ) CN¥18.16b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 002727 income statement (TTM ) Revenue CN¥18.16b Cost of Revenue CN¥12.52b Gross Profit CN¥5.64b Other Expenses CN¥5.48b Earnings CN¥156.02m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) 0.27 Gross Margin 31.05% Net Profit Margin 0.86% Debt/Equity Ratio 6.3%
How did 002727 perform over the long term?
See historical performance and comparison Dividends
2.9% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/22 02:40 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Yixintang Pharmaceutical Group Co., Ltd. is covered by 20 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Haigang Chen China International Capital Corporation Limited Feifei Xu China Merchants Securities Co. Ltd. Bing Zhao China Renaissance Securities
Show 17 more analysts